Addyi (Flibanserin 100 mg) is the first and the only officially approved remedy for acquired reduced sexual desire in women before menopause. This non-hormonal drug is suitable for women with a low sexual desire that does not depend on the circumstances, who have not had any problems with sexual desire before. However, their problem should not come from:
Physical or mental illness;
Reception of medical preparations.
Fliban is not intended for use by women after menopause, men, and children. Also, the drug is not suitable for improving sexual performance.
According to the Food and Drug Administration, taking Flibanserin can lead to the following side effects: dizziness, drowsiness, nausea, pathological fatigue, insomnia, and dry mouth. Fliban is not recommended for people with low blood pressure. Side effects can be aggravated if you violate the rules of taking medicine (not at bedtime). Also, the likelihood of hypotension and fainting significantly increases the intake of the drug with alcohol.